Guide to Targeted Therapies: Egfr Mutations in Nsclc

About this Book

• A concise, practical handbook on EGFR mutations in NSCLC that provides oncologists and other healthcare providers with an up-to-date review of the background and advances in the field
• Reviews the current treatment recommendations for EGFR mutations in NSCLC and emerging treatment options based on recent clinical trials
• Easily accessible text, tables, and images reviews the critical clinical trials, giving readers a fast synopsis of key studies and available treatment options

Guide to Targeted Therapies: EGFR Mutations in NSCLC is a speedy and up-to-date review, which discusses EGFR mutations, testing methods and technology, current and emerging therapies, and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of EGFR gene mutations as well as a summary of current therapies will benefit from this succinct guide.

Content Level » Professional/practitioner
Keywords » Epidermal growth factor receptor - Non-small cell lung cancer - Oncology -Pulmonology
Related subjects » Adis

Table of Contents

Overview of NSCLC.- EGFR mutations in NSCLC.- EGFR-testing methods and technology.- EGFR-targeted treatment.- Resources for your patient

Authors & Editors

Federico Cappuzzo is the Director of the Medical Oncology Department (Ospedale Civile in Livorno, Italy), following posts as Assistant Professor (Ospedale Bellaria in Bologna, Italy, the Istituto Clinico Humanitas IRCCS in Milan, Italy, and University of Colorado in Denver, USA). Dr Cappuzzo is a member of the Italian Association in Medical Oncology (AIOM), European Society for Medical Oncology (ESMO), American Society Clinical Oncology (ASCO) and International Association for the Study of Lung Cancer (IASCL). He also sits on the editorial board of Lung Cancer.